Bio-Techne
TECH
550 hedge funds and large institutions have $12.9B invested in Bio-Techne in 2022 Q2 according to their latest regulatory filings, with 59 funds opening new positions, 183 increasing their positions, 224 reducing their positions, and 58 closing their positions.
286% more call options, than puts
Call options by funds: $11.6M | Put options by funds: $3.01M
2% more first-time investments, than exits
New positions opened: 59 | Existing positions closed: 58
1% less funds holding
Funds holding: 557 → 550 (-7)
4.87% less ownership
Funds ownership: 384% → 379.13% (-4.9%)
17% less funds holding in top 10
Funds holding in top 10: 12 → 10 (-2)
18% less repeat investments, than reductions
Existing positions increased: 183 | Existing positions reduced: 224
21% less capital invested
Capital invested by funds: $16.3B → $12.9B (-$3.44B)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Select Equity Group
New York
|
+$234M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$68M |
| 3 |
Marshall Wace
London,
United Kingdom
|
+$63.3M |
| 4 |
Morgan Stanley
New York
|
+$46.8M |
| 5 |
Renaissance Technologies
New York
|
+$42.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
William Blair Investment Management
Chicago,
Illinois
|
-$206M |
| 2 |
FAM
Fred Alger Management
New York
|
-$122M |
| 3 |
OCBV
Ownership Capital B.V.
Amsterdam,
Netherlands
|
-$69.2M |
| 4 |
BlackRock
New York
|
-$43.5M |
| 5 |
OWP
Obermeyer Wealth Partners
Aspen,
Colorado
|
-$43.4M |
TECH Hedge Fund Activity: Q2 2022 in Review
550 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in Bio-Techne (TECH) for Q2 2022, worth a combined $12.9B — down 21% from $16.3B a quarter earlier.
Buyers outnumbered sellers: 59 funds opened new TECH positions and 58 closed out — a net gain of 1 holder — while 183 added to existing stakes and 224 trimmed.
The largest buyer was Select Equity Group, adding an estimated $234M. The largest seller was William Blair Investment Management, exiting entirely with an estimated $206M sold.
- 550 institutional investors held Bio-Techne (TECH) as of Q2 2022, down from 557 in Q1 2022.
- Funds reported $12.9B of Bio-Techne stock for Q2 2022, down 21% quarter-over-quarter.
- 59 funds opened new Bio-Techne positions in Q2 2022 and 58 closed out, a net change of +1 holder.
- The largest Bio-Techne buyer in Q2 2022 was Select Equity Group, an estimated $234M added.
- The largest Bio-Techne seller in Q2 2022 was William Blair Investment Management, an estimated $206M sold.
Based on aggregated 13F filings for Q2 2022.